Measuring lung function in children with cerebral palsy using a non-invasive sensor
Non-Invasive Measurement of Pulmonary Dysfunction in Children With Cerebral Palsy
NA · Nemours Children's Clinic · NCT05791877
This study is testing a new non-invasive sensor to see how well children with severe cerebral palsy breathe and if their lung function is related to the severity of scoliosis.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 250 (estimated) |
| Ages | 5 Years to 17 Years |
| Sex | All |
| Sponsor | Nemours Children's Clinic (other) |
| Locations | 1 site (Wilmington, Delaware) |
| Trial ID | NCT05791877 on ClinicalTrials.gov |
What this trial studies
This project aims to assess pulmonary dysfunction in children with severe cerebral palsy by employing a novel non-invasive respiratory sensor called pneuRIP. The sensor utilizes Respiratory Inductance Plethysmography to passively measure pulmonary function without requiring active participation from the child. It records various indices of breathing effort and can provide real-time data wirelessly to an iPad. The study seeks to establish a correlation between pulmonary dysfunction and scoliosis severity in this population, potentially improving diagnosis and treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are children diagnosed with cerebral palsy classified at GMFCS levels IV and V.
Not a fit: Patients with cerebral palsy who are not at GMFCS levels IV or V may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a simple and effective tool for monitoring respiratory health in children with cerebral palsy, reducing the risk of respiratory complications.
How similar studies have performed: While the approach of using non-invasive sensors for pulmonary function measurement is innovative, similar studies have shown promise in other populations, suggesting potential for success in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects should have cerebral palsy a GMFCS levels IV, V Exclusion Criteria: \-
Where this trial is running
Wilmington, Delaware
- Nemours Children's Hospital — Wilmington, Delaware, United States (RECRUITING)
Study contacts
- Principal investigator: Tariq Rahman, PhD — Principal Research Engineer
- Study coordinator: Tariq Rahman, PhD
- Email: trahman@nemours.org
- Phone: 6104539376
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cerebral Palsy